BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26268355)

  • 1. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana.
    Anderson M; Gaseitsiwe S; Moyo S; Wessels MJ; Mohammed T; Sebunya TK; Powell EA; Makhema J; Blackard JT; Marlink R; Essex M; Musonda RM
    BMC Infect Dis; 2015 Aug; 15():335. PubMed ID: 26268355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of hepatitis B virus in blood donors in Botswana.
    Choga WT; Anderson M; Zumbika E; Moyo S; Mbangiwa T; Phinius BB; Melamu P; Kayembe MK; Kasvosve I; Sebunya TK; Blackard JT; Essex M; Musonda RM; Gaseitsiwe S
    Virus Genes; 2019 Feb; 55(1):33-42. PubMed ID: 30382563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.
    Matthews PC; Beloukas A; Malik A; Carlson JM; Jooste P; Ogwu A; Shapiro R; Riddell L; Chen F; Luzzi G; Jaggernath M; Jesuthasan G; Jeffery K; Ndung'u T; Goulder PJ; Geretti AM; Klenerman P
    PLoS One; 2015; 10(7):e0134037. PubMed ID: 26218239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.
    Aghakhani A; Mohraz M; Aghasadeghi MR; Banifazl M; Vahabpour R; Karami A; Foroughi M; Ramezani A
    Int J STD AIDS; 2016 Oct; 27(11):967-72. PubMed ID: 26384943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon.
    Magoro T; Gachara G; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong P
    Virol J; 2016 Oct; 13(1):178. PubMed ID: 27769271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan.
    Yousif M; Mudawi H; Hussein W; Mukhtar M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():125-32. PubMed ID: 25449246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection.
    Pourkarim MR; Lemey P; Amini-Bavil-Olyaee S; Houspie L; Verbeeck J; Rahman M; Maes P; Vanwijngaerden E; Nevens F; Van Ranst M
    J Med Virol; 2011 Nov; 83(11):1876-84. PubMed ID: 21915860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.
    Pal A; Sarkar N; Saha D; Guha SK; Saha B; Chakrabarti S; Chakravarty R
    Antivir Ther; 2015; 20(5):545-54. PubMed ID: 25654813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    Deressa T; Damtie D; Fonseca K; Gao S; Abate E; Alemu S; Aleka Y; Swain MG; van Marle G; Coffin CS
    PLoS One; 2017; 12(12):e0190149. PubMed ID: 29281718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
    Dao DY; Balko J; Attar N; Neak E; Yuan HJ; Lee WM; Jain MK
    J Med Virol; 2011 Sep; 83(9):1551-8. PubMed ID: 21739445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.
    Archampong TN; Boyce CL; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Blackard JT; Kwara A
    Antivir Ther; 2017; 22(1):13-20. PubMed ID: 27167598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.
    Lee Z; Nishikawa S; Gao S; Eksteen JB; Czub M; Gill MJ; Osiowy C; van der Meer F; van Marle G; Coffin CS
    PLoS One; 2015; 10(9):e0137568. PubMed ID: 26390290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
    Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
    World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencing.
    Tangkijvanich P; Sa-Nguanmoo P; Avihingsanon A; Ruxrungtham K; Poovorawan K; Poovorawan Y
    J Med Virol; 2013 Jan; 85(1):16-25. PubMed ID: 23024025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombination of hepatitis B virus DNA in patients with HIV.
    Fallot G; Halgand B; Garnier E; Branger M; Gervais A; Roque-Afonso AM; Thiers V; Billaud E; Matheron S; Samuel D; Féray C
    Gut; 2012 Aug; 61(8):1197-208. PubMed ID: 22068164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
    Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
    Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance.
    Bautista-Amorocho H; Castellanos-Domínguez YZ; Rodríguez-Villamizar LA; Velandia-Cruz SA; Becerra-Peña JA; Farfán-García AE
    PLoS One; 2014; 9(12):e114272. PubMed ID: 25462190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
    Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
    Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana.
    Phinius BB; Anderson M; Bokete R; Mbangiwa T; Choga WT; Baruti K; Makhema J; Musonda R; Blackard JT; Essex M; Moyo S; Marlink R; Gaseitsiwe S
    Medicine (Baltimore); 2020 Feb; 99(9):e19341. PubMed ID: 32118769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.